There is a correlation between PLK4 expression in gliomas and tumor grades, subtypes, and new WHO types of gliomas (IDH mutation +1p19q codel, IDH mutation +1p19q non-codel, and IDH wild type) (Supplementary Figures 1A–L). This evidence concerns the gene PLK4 and central nervous system cancer.